SCHEMBL20178592

SCHEMBL20178592

CCCC(CCC)c1ccc(C(=O)OC)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 4/20 0.43
NOTUM Q6P988 2/20 0.40
AKR1C3 P42330 6/20 0.39
AKR1C2 P52895 6/20 0.39
AKR1B10 O60218 2/20 0.39
AKR1C4 P17516 2/20 0.39
AKR1C1 Q04828 2/20 0.39
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK4 Q16654 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CES2 O00748 1/20 0.36
ESRRA P11474 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20173743 0.81 CFTR (0.48) CFTRNOTUMAKR1C3AKR1C2AKR1C4
SCHEMBL20178581 0.81 THRA (0.41) CFTRNOTUMKDM4EALDH1A1
SCHEMBL10309762 0.77 CFTR (0.49) CFTRNOTUMKDM4EMAPTCA12
SCHEMBL23666705 0.76 ESR1 (0.36) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL20178593 0.74 PPARA (0.46) CFTRNOTUMKDM4EALDH1A1LMNA
SCHEMBL16726459 0.74 THRA (0.60) CFTRKDM4EMAPTESRRAALDH1A1
SCHEMBL25935035 0.74 THRA (0.54) CFTRNOTUMKMT2AMAPTESRRA
SCHEMBL13948877 0.73 CFTR (0.51) CFTRNOTUMKDM4EMAPTCA12
SCHEMBL2002005 0.73 CFTR (0.69) CFTRNOTUMKDM4EMAPTCA12
SCHEMBL1940800 0.73 CA12 (0.61) CFTRNOTUMKDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2020-03-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF NR1H4, FXR1, SLC10A1 CFTR 32/4885NOTUM 1474/4885AKR1C3 1156/4885
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof NR1H4, FXR1, SLC10A1 CFTR 32/4885NOTUM 1474/4885AKR1C3 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.